When should the heparin‑induced thrombocytopenia (HIT) panel be drawn for a patient on heparin whose platelet count fell from 102 ×10⁹/L to 67 ×10⁹/L?

When to Draw HIT Panel

Draw the HIT panel immediately – this patient has a >50% platelet drop (from 102 to 67 ×10⁹/L, representing a 34% decrease) while on heparin, which mandates urgent evaluation for HIT regardless of timing 1.

Clinical Context

This platelet decline meets the threshold for HIT evaluation. The FDA label explicitly states: "If the platelet count falls below 100,000/mm³ or if recurrent thrombosis develops, promptly discontinue heparin, evaluate for HIT and HITT" 1. Your patient's count of 67 ×10⁹/L is well below this threshold.

Immediate Actions Required

While awaiting HIT panel results:

1. Calculate the 4Ts score immediately to estimate pre-test probability 2

   • Thrombocytopenia severity and timing
   • Thrombosis presence
   • Other causes for thrombocytopenia
   • Prior heparin exposure

2. If 4Ts score is intermediate (4-5) or high (6-8):

   • Stop ALL heparin products immediately (including flushes and heparin-coated catheters) 2, 3
   • Start alternative anticoagulation with argatroban, lepirudin, or danaparoid at therapeutic doses 2, 3
   • Do NOT wait for laboratory confirmation to change anticoagulation

3. Order both immunoassay and functional assay if available 2

   • Immunoassay (ELISA for PF4/heparin antibodies) provides high sensitivity
   • Functional assay (serotonin release assay or HIPA) provides higher specificity
   • Request quantitative optical density values, not just positive/negative

Critical Timing Considerations

The timing of when heparin was started matters significantly:

• If heparin started >5 days ago: This platelet drop fits typical-onset HIT (days 5-14) 2, 4
• If heparin started within past 4 days BUT patient had heparin exposure in the preceding 30-100 days: This could be rapid-onset HIT from pre-existing antibodies 2, 5, 6

Common Pitfalls to Avoid

Do not delay testing or treatment based on timing alone. While HIT classically occurs days 5-14, the severity of thrombocytopenia (drop to 67 ×10⁹/L) and crossing below 100 ×10⁹/L threshold makes this urgent regardless of when heparin was initiated 1.

Do not wait for thrombosis to develop. Isolated HIT (without thrombosis) still requires immediate heparin cessation and alternative anticoagulation, as the risk of thrombosis is dramatically elevated (odds ratio 37) 7, 8.

Do not give prophylactic platelet transfusions – these can worsen thrombotic risk 3.

Do not start warfarin until platelets recover to ≥150 ×10⁹/L and patient is therapeutically anticoagulated with alternative agent for minimum 5 days 3.

Risk Stratification

The 2018 ASH guidelines emphasize that intermediate or high 4Ts scores mandate immunoassay testing 2. Given your patient's significant platelet drop below 100 ×10⁹/L, this testing should occur stat, not as a send-out that delays clinical decision-making.

If renal function is normal, argatroban or lepirudin are preferred alternative anticoagulants; if renal insufficiency exists, argatroban is specifically recommended 3.